CT Scores Predict Mortality in 2019-nCoV Pneumonia

CT Scores Predict Mortality in 2019-nCoV Pneumonia Clinical Trial

Official title:

CT Scores Predict Mortality in 2019-nCoV Pneumonia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04284046
• Other study ID #: CT2019-nCoV
• Status: Completed
• Start date: January 31, 2020
• Est. completion date: February 18, 2020

Study information

• Verified date: February 2020
• Source: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

While 2019-nCoV nucleic acid swab tests has high false positives rate, How to diagnose 2019-nCoV pneumonia and predict prognosis by CT is very important.In this retrospective single-center study, we consecutively included suspected 2019-nCoV pneumonia critical cases in the intensive care unit of Wuhan third hospital from January 31, 2020 to February 16, 2020. The cases were confirmed by real-time RT-PCR, and all patients were evaluated with CT, cutoff values were obtained according to the Yoden index, and were divided into high CT score group and low CT score group. Epidemiological, demographic, clinical, and laboratory data were collected.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 39
• Est. completion date: February 18, 2020
• Est. primary completion date: February 18, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• all patients suspected of 2019 novel coronavirus infection.

Exclusion Criteria:

• patients' data are not available.

Related Conditions & MeSH terms

• CT Scores Predict Mortality in 2019-nCoV Pneumonia
• Pneumonia

Intervention

Other:
• CT score
CT score = normal lung tissue (%) ×1 + GGO (%) ×2 + consolidation (%) ×3

Locations

Country	Name	City	State
China	Wuhan third hospital	Wuhan	Hubei

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	7-day mortality		7-day